Close Asset Management »

Celldex Therapeutics shares owned by Close Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Close Asset Management from 13F filings

Historical chart of Close Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Close Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Close Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0k 133 37.59
2023-09-30 $4.0k 133 30.08